“In the US, remdesivir is being used as an emergency treatment for patients with COVID-19. Remdesivir is administered intravenously and has been authorised for the treatment of hospitalised patients with severe COVID-19 symptoms in the US. Recent clinical trials have shown evidence that remdesivir helps COVID-19 patients recover faster. Japan has also granted special approval for the emergency use of remdesivir to treat COVID-19 patients. “We are pleased to be the first generic company in the world to introduce this very important drug for treating the hospitalised COVID-19 patients,” he said.

Source: bd News24 May 21, 2020 11:48 UTC